162 related articles for article (PubMed ID: 34558610)
1. BASDAI cut-off values corresponding to ASDAS cut-off values.
Kwon OC; Park MC
Rheumatology (Oxford); 2022 May; 61(6):2369-2374. PubMed ID: 34558610
[TBL] [Abstract][Full Text] [Related]
2. Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values.
Cui R; Du Y; Tian N; Jiang HL; Tao YL; Dai SM
Clin Exp Rheumatol; 2023 May; 41(5):1163-1169. PubMed ID: 36226617
[TBL] [Abstract][Full Text] [Related]
3. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
4. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
[TBL] [Abstract][Full Text] [Related]
5. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
Kilic G; Kilic E; Ozgocmen S
Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
[TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
[TBL] [Abstract][Full Text] [Related]
7. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
[TBL] [Abstract][Full Text] [Related]
8. The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis.
Chen YH; Huang WN; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Chen YJ; Liao YW; Chen HH
Front Med (Lausanne); 2022; 9():856654. PubMed ID: 35652077
[TBL] [Abstract][Full Text] [Related]
9. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
10. Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?
Au YL; Wong WS; Mok MY; Chung HY; Chan E; Lau CS
Clin Rheumatol; 2014 Aug; 33(8):1127-34. PubMed ID: 24981160
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.
Godfrin-Valnet M; Prati C; Puyraveau M; Toussirot E; Letho-Gyselink H; Wendling D
Joint Bone Spine; 2013 Jul; 80(4):393-8. PubMed ID: 23453478
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.
Kılıç G; Kılıç E; Nas K; Karkucak M; Çapkın E; Dağlı AZ; Çevik R; Özgöçmen S
Clin Rheumatol; 2015 Mar; 34(3):515-21. PubMed ID: 24985042
[TBL] [Abstract][Full Text] [Related]
13. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.
Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM
Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863
[TBL] [Abstract][Full Text] [Related]
14. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
Di Carlo M; Lato V; Carotti M; Salaffi F
Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
[TBL] [Abstract][Full Text] [Related]
15. Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study.
Nam B; Koo BS; Lee TH; Shin JH; Kim JJ; Lee S; Joo KB; Kim TH
BMC Musculoskelet Disord; 2021 Feb; 22(1):140. PubMed ID: 33541326
[TBL] [Abstract][Full Text] [Related]
16. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
DU XN; Li Y; Zhang SL; Zhu J; Huang F
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
[TBL] [Abstract][Full Text] [Related]
17. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
[TBL] [Abstract][Full Text] [Related]
18. How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula.
Aranda-Valera IC; Garrido-Castro JL; Ladehesa-Pineda L; Vazquez-Mellado J; Zarco P; Juanola X; Gonzalez-Navas C; Font-Ugalde P; Castro-Villegas MC
Rheumatology (Oxford); 2020 Jul; 59(7):1545-1549. PubMed ID: 31628804
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis.
Senabre Gallego JM; Rosas J; Marco-Mingot M; García-Gómez JA; Santos-Soler G; Salas-Heredia E; Pons-Bas A; Barber-Vallés X; Bernal-Vidal JA; Cano-Pérez C; García-Carrasco M; Flores-Pardo E;
Rheumatol Int; 2019 May; 39(5):841-849. PubMed ID: 30899987
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable.
Ortolan A; Ramiro S; van Gaalen F; Kvien TK; Landewe RBM; Machado PM; Ruyssen-Witrand A; van Tubergen A; Bastiaenen C; van der Heijde D
Rheumatology (Oxford); 2021 Feb; 60(2):638-648. PubMed ID: 32572483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
